News & Events CTI Announces Patrick J. Earley Promoted to Vice President, International

CTI Announces Patrick J. Earley Promoted to Vice President, International

May 12, 2014

CTI Clinical Trial and Consulting Services Announces Patrick J. Earley Promoted to Vice President, International

FOR IMMEDIATE RELEASE [Cincinnati, OH ~ May 12, 2014]

CTI Clinical Trial and Consulting Services (CTI) announces Patrick J. Earley, MBA has been promoted to Vice President, International, leading the strategic global expansion and oversight in Europe and Latin America.

Earley has been with CTI for over five years, serving as General Manager, creating and overseeing a variety of aspects that have been vital to the clinical and operational growth of the company.

Prior to joining CTI, he held positions in the healthcare and insurance industries, with MetLife and First Health. Pat received his Bachelor of Science in Business Administration from West Liberty State College and his Master of Business Administration in Finance from Xavier University.

“Since joining CTI, Pat has been instrumental in identifying, selecting, and managing geographic expansion, including technology, real estate, recruitment, and personnel management,” according to Timothy J. Schroeder, Chief Executive Officer. “His leadership has resulted in a passionate, dedicated, professional international workforce with an industry leading retention rate exceeding 95%.”

“I look forward to leading further expansion at CTI, with a focus on exploring more opportunities to grow our base in the Latin America and Pacific Asia regions,” said Earley.

About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and deliver high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.

Original Press Release

Subscribe to our mailing list

* indicates required